Literature DB >> 6514112

Metabolic studies in vitro of the CNS cytoskeletal proteins: synthesis and degradation.

M E Smith, V Perret, L F Eng.   

Abstract

General aspects of metabolic features of the most prominent CNS intermediate filament proteins, the 200,000 (200K), 150,000 (150K), and 70,000 (70K) dalton proteins of the neuron, and the glial fibrillary acidic protein (GFAP) have been explored using the incubated spinal cord slice from the rat. Measurement of short-term uptake of 3H-labeled amino acids into the individual proteins separated on polyacrylamide gels revealed that of the three neurofilament proteins, 200K was most metabolically active, 150K was less active, and 70K contained very little incorporated radioactivity. Glial fibrillary acidic protein based on Coomassie blue stain affinity showed less metabolic activity than any of the neurofilament proteins. Those relationships were constant at all ages, but the metabolic activity of all CNS intermediate filaments decreased with age. When Ca2+ was present in the medium of the incubated slices, the intermediate filaments were rapidly destroyed, but GFAP was more resistant to degradation than the neurofilament proteins. GFAP and probably the neurofilament proteins also were relatively resistant to Ca2+-activated degradative mechanisms in spinal cords of rats at younger ages (15 day) than in those of older animals (10-18 months). It is likely that the Ca2+ activated protease is less active in developing animals in which the nerve tracts are still elongating, than in adults. These results suggest that GFAP is less active metabolically and more resistant to degradation than the neurofilament proteins at all stages of maturation, but that metabolic activity of all CNS intermediate filaments decreases with age while the susceptibility to degradation increases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6514112     DOI: 10.1007/bf00964675

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  16 in total

1.  A NEUTRAL, CALCIUM-ACTIVATED PROTEINASE FROM THE SOLUBLE FRACTION OF RAT BRAIN.

Authors:  G GUROFF
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors.

Authors:  L F Eng; L J Rubinstein
Journal:  J Histochem Cytochem       Date:  1978-07       Impact factor: 2.479

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Study of glial fibrillary acidic protein in a human glioma cell line grown in culture and as a solid tumor.

Authors:  J W Bigbee; D D Bigner; C Pegram; L F Eng
Journal:  J Neurochem       Date:  1983-02       Impact factor: 5.372

6.  Bulk preparation of CNS cytoskeleton and the separation of individual neurofilament proteins by gel filtration: dye-binding characteristics and amino acid compositions.

Authors:  F C Chiu; W T Norton
Journal:  J Neurochem       Date:  1982-11       Impact factor: 5.372

7.  Synthesis and turnover of cytoskeletal proteins in cultured astrocytes.

Authors:  F C Chiu; J E Goldman
Journal:  J Neurochem       Date:  1984-01       Impact factor: 5.372

8.  Preparation of neurofilament protein from guinea pig peripheral nerve and spinal cord.

Authors:  G Shecket; R J Lasek
Journal:  J Neurochem       Date:  1980-12       Impact factor: 5.372

9.  Studies on the biosynthesis of neurofilament proteins.

Authors:  H Czosnek; D Soifer; H M Wisniewski
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

10.  The slow component of axonal transport. Identification of major structural polypeptides of the axon and their generality among mammalian neurons.

Authors:  P N Hoffman; R J Lasek
Journal:  J Cell Biol       Date:  1975-08       Impact factor: 10.539

View more
  7 in total

1.  Glial fibrillary acidic protein exhibits altered turnover kinetics in a mouse model of Alexander disease.

Authors:  Laura R Moody; Gregory A Barrett-Wilt; Michael R Sussman; Albee Messing
Journal:  J Biol Chem       Date:  2017-02-21       Impact factor: 5.157

2.  Proteolysis of filament proteins in glial and neuronal cells after in vivo stimulation of hippocampal NMDA receptors.

Authors:  S Wang; G J Lees; L E Rosengren; J E Karlsson; A Hamberger; K G Haglid
Journal:  Neurochem Res       Date:  1992-10       Impact factor: 3.996

3.  Ca2+-mediated degradation of central nervous system (CNS) proteins: topographic and species variation.

Authors:  N L Banik; R D Happel; M B Sostek; F C Chiu; E L Hogan
Journal:  Metab Brain Dis       Date:  1987-06       Impact factor: 3.584

4.  Calpain II activity and calpastatin content in brain regions of 3- and 24-month-old rats.

Authors:  A Kenessey; M Banay-Schwartz; T DeGuzman; A Lajtha
Journal:  Neurochem Res       Date:  1990-03       Impact factor: 3.996

5.  Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light.

Authors:  Faiez Al Nimer; Eric Thelin; Harriet Nyström; Ann M Dring; Anders Svenningsson; Fredrik Piehl; David W Nelson; Bo-Michael Bellander
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

6.  MicroRNAs Deregulated in Intraductal Papillary Mucinous Neoplasm Converge on Actin Cytoskeleton-Related Pathways That Are Maintained in Pancreatic Ductal Adenocarcinoma.

Authors:  Elena Fernandez-Castañer; Maria Vila-Casadesus; Elena Vila-Navarro; Carolina Parra; Juan Jose Lozano; Antoni Castells; Meritxell Gironella
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

Review 7.  A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury.

Authors:  Eric Peter Thelin; David W Nelson; Bo-Michael Bellander
Journal:  Acta Neurochir (Wien)       Date:  2016-12-12       Impact factor: 2.216

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.